Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017

Psychopharmacology

Volumn 135, Issue 4, 1998, Pages 407-415

  Terry Jr , Alvin V ^a,b   Buccafusco, Jerry J ^a,b   Jackson, William J ^a   Prendergast, Mark A ^a,b   Fontana, David J ^c   Wong, Erik H F ^c   Bonhaus, Douglas W ^c   Weller, Paul ^c   Eglen, Richard M ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Center for Biological Research   (United States)

Author keywords

Alzheimer's disease; Cholinergic; Learning and memory; Monkey; Pharmacokinetics; Receptor binding; Serotonin

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 5 (PIPERIDIN 1 YL) 1 PENTANONE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 ETHYL 2,3 DIHYDRO 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 3ALPHA TROPANYLAMIDE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 AMINOBUTYRIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DIZOCILPINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ISRADIPINE; KETANSERIN; MESULERGINE; METHYSERGIDE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NEUROTRANSMITTER RECEPTOR; PIRENZEPINE; PRAZOSIN; QUIPAZINE; RADIOLIGAND; RAUWOLSCINE; RS 17017; SAXITOXIN; SEROTONIN; SEROTONIN 4 AGONIST; SPIPERONE; TRITIUM; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEMORY; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TASK PERFORMANCE;

AGING; ANIMALS; BINDING, COMPETITIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; KINETICS; MACACA FASCICULARIS; MACACA MULATTA; MACACA NEMESTRINA; MALE; MEMORY; PENTANONES; PIPERIDINES; PSYCHOMOTOR PERFORMANCE; RADIOLIGAND ASSAY; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS;

EID: 15644368250     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050529     Document Type: Article

References (72)

1. Aït Amara D, Segu L, Naili S, Buhot MC (1995) Serotonin IB receptor regulation after dorsal subiculum deafferentation. Brain Res Bull 38: 17
2. Altman HJ, Normile HJ (1987) Different temporal effects of serotonergic antagonists on passive avoidance retention. Pharmacol Biochem Behav 28: 353-359
3. Altman HJ, Normile HJ (1988) What is the nature of the role of the serotonergic nervous system in learning and memory? Prospects for development of an effective treatment strategy for senile dementia. Neurobiol Aging 9: 627-638
4. Altman HJ, Normile HJ, Galloway MP, Ramirez A, Azmitia EC (1990) Enhanced spatial discrimination learning in rats following 5,7-DHT-induced serotonergic deafferentation of the hippocampus. Brain Res 518: 61
5. Altman PL, Dittmer DS (eds) (1961) Blood and other body fluids. Federation of American Societies for Experimental Biology, Washington, DC
6. Altman PL, Dittmer DS (eds) (1974) Biology data book. (2nd edn). 1972-1974, vol I-III. Federation of American Societies for Experimental Biology, Bethesda, Md
7. Asin KE, Wirtshafter D, Fibiger HC (1985) Electrolytic, but not 5,7-dihydroxytryptamine, lesions of the nucleus medianus raphe impair acquisition of a radial L-maze task. Behav Neural Biol 44: 415
8. 3 recognition sites in human brain tissue. J Neurochem 53: 1787-1793
9. 3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338|6218|: 762-763
10. Bass EW, Means LW, McMillen BA (1992) Buspirone impairs performance of a three-choice working memroy water escape task in rats. Brain Res Bull 28: 455
11. 4 receptors: potential therapeutic implications in neurology and psychiatry. CNS Drugs 1:6-15
12. Briley M (1990) Biochemical strategies in the search for cognition enhancers. Pharmacopsychiatry 23[Suppl]: 75-80
13. 1B receptors in the rat. Eur J Pharmacol 285: 221-228
14. Carey GJ, Costall B, Domeney AM, Gerrard PA, Jones DN, Naylor RJ, Tyers MB (1992) Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset. Pharmacol Biochem Behav 42: 75-83
15. 1A receptors. Br J Pharmacol 105: 720
16. Cassel JC, Jeltsch H (1995) Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience 69: 1-41
17. 50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108
18. 3 antagonist ICS 205-930. Pharmacol Toxicol 69: 105-106
19. Chugh Y, Saha N, Sankaranarayanan A, Sharma P (1991b) Memory enhancing effects of granisetron (BRL 43694) in a passive avoidance task. Eur J Pharmacol 203: 121-123
20. 4 receptor agonist properties. Bioorg Med Chem Lett 3: 1375-1378
21. 4 receptor antagonist RS-23597 are high affinity partial agonists. Bioorg Med Chem Lett 4: 2477-2480
22. Cross AJ, Slater P, Perry E, Perry RH (1988) An autoradiographic analysis of serotonin receptors in human temporal cortex: changes in Alzheimer-type dementia. Neurochem Int 13: 89-96
23. DeNoble VJ, Schrack LM, Reigel AL, DeNoble KF (1991) Visual recognition memory in squirrel monkeys: effects of serotonin antagonists on baseline and hypoxia-indnced performance deficits. Pharmacol Biochem Behav 39: 991-996
24. Dunnet SB, Wareham AT, Torres EM (1990) Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats. Neuroreport 1: 61-64
25. Eglen RM (1997) 5-Hydroxytryptamine (5-HT4) receptors and central nervous system function: an update. Prog Drug Res 49: 9-21
26. 4 receptors. Trends Pharmacol Sci 16: 391-398
27. 4 receptor agonists, RS 67333 and RS 67506, in vitro and in vivo. Br J Pharmacol 115: 1387-1392
28. Flood JF, Cherkin A (1987) Fluoxetine enhances memory in mice. Psychopharmacology 93: 36-43
29. Fontana DJ, Daniels SE, Henderson C, Eglen RM, Wong EHF (1995) Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. Psychopharmacology 120: 409-417
30. Graham S, Ho M-Y, Bradshaw CM, Szabadi E (1994) Facilitated acquisition of a temporal discrimination following destruction of the ascending 5-hydroxytryptaminergic pathways. Psychopharmacology 116: 373-378
31. Irle E, Kessler J, Markowitsch HJ (1987) Primate learning tasks reveal strong impairments in patients with presenile dementia of the Alzheimer's type. Brain Cogn 6: 429-449
32. Jackson WJ, Elrod K, Buccafusco JJ (1989) Delayed matching-to-sample in monkeys as a model for learning and memory deficits: role of brain nicotinic receptors. Adv Behav Biol 36: 39-52
33. Jaffard R, Meunier M (1993) Role of the hippocampal formation in learning and memory. Hippocampus 3: 203
34. 1A receptors are expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of broca - a double immunocytochemical study. Neuroscience 75: 143-154
35. 3 receptors in rat brain using radioligand binding. Nature 330: 746-768
36. Lipska BK, Jaskiw GE, Arya A, Weinberger DR (1992) Serotonin depletion causes long-term reduction of exploration in the rat. Pharmacol Biochem Behav 43: 1247
37. 4 receptors in guinea-pig colon and rat oesophagus: effects of novel agonists and antagonists. Naunyn Schmiedeberg's Arch Pharmacol 354: 145-156
38. 1 sites in the rat brain. Brain Res 291: 159
39. 1B receptors mediating inhibition of acetylcholine release. Eur J Pharmacol 129: 333-337
40. 3 receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release. J Neurochem 58: 2334-2337
41. 1A receptor agonists induce anterograde amnesia in mice through a postsynaptic mechanism. Eur J Pharmacol 236: 177-182
42. Middlemiss DN, Palmer AM, Edel N, Bowen DM (1986) Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin in normal and Alzheimer brain. J Neurochem 46: 993-996
43. Milner TA, Veznedaroglu E (1993) Serotonin-containing terminals synapse on septohippocampal neurons in the rat. J Neurosci Res 36: 260-271
44. Muir JL, Everitt BJ, Robbins TW (1994) AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 14: 2313-2326
45. Normile AJ, Jenden DJ, Kuhn DM, Wolf WA, Altman HJ (1990) Effects of combined serotonin depletion and lesions of the nucleus basalis magnocellularis on acquisition of a complex spatial discrimination task in the rat. Brain Res 536: 245-250
46. Oscar-Berman M, Bonner RT (1985) Matching-and delayed matching-to-sample performance as measures of visual processing, selective attention, and memory in aging and alcoholic individuals. Neuropsychologia 23: 639-651
47. Palmer AM (1996) Neurochemical studies of Alzheimer's disease. Neurodegeneration 5: 371-391
48. Paxinos G (1985) The rat nervous system. Volume 1. Forebrain and midbrain. Academic Press, San Diego
49. Perryman KM, Fitten LJ (1993) Delayed matching-to-sample performance during a double blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease. Life Sci 53: 479-486
50. 3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task. Pharmacol Biochem Behav 47: 95-99
51. Price DL, Sisodia SS (1994) Cellular and molecular biology of Alzheimer's disease and animal models. Annu Rev Med 45: 435-446
52. 1A receptor agonists on septal cholinergic neurons in culture. Dev Brain Res 82: 245-258
53. Ricaurte GA, Markowska AL, Wenk GL, Hatzidimitriou G, Wlos J, Olton DS (1993) 3,4-Methylenedioxymethamphetamine, serotonin and memory. J Pharmacol Exp Ther 266: 1097
54. Riekkinen PJ, Sirviö J, Valjakka A, Miettinen R, Riekkinen P (1991) Pharmacological consequences of cholinergic plus serotonergic manipulations. Brain Res 552: 23-26
55. Roberts AC, Robbins TW, Everitt BJ, Muir JL (1992) A specific form of cognitive rigidity following excitotoxic lesions in the basal forebrain in marmosets. Neuroscience 47: 251-264
56. Rogers SL, Friedhoff LT (1994) E2020 improves cognition and quality of life in patients with mild-to-moderate Alzheimer's disease: results of a phase-II trail. Neurology 44[Suppl 2]: 165
57. 3H]acetylcholine release from mouse cerebral cortical synaptosomes. J Neurochem 43: 1595-1598
58. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddinglon S, Crayton L, Crockford HA, Crooks M, ,Hill K, Levy R (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 110: 395-401
59. Schneider LS (1993) Clinical pharmacology of aminoacridines in Alzheimer's disease. Neurology 43[Suppl 4|: S64-S79
60. Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40: 503-509
61. Smith ML, Booze RM (1995) Cholinergic and gabaergic neurons in the nucleus basalis region of young and aged rats. Neuroscience 67: 679-688
62. Squire LR, Zola-Morgan S, Chen SK (1988) Human amnesia and animal models of amnesia: performance of amnesic patients on tests designed for the monkey. Behav Neurosci 102: 210-221
63. Strek KF, Spencer KR, DeNoble VJ, Manipulation of serotonergic protects against a hypoxia-induced deficit of a passive avoidance response in rats. Pharmacol Biochem Behav 33: 241-244
64. Terry AV Jr, Buccafusco JJ, Jackson WJ (1993) Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacol Biochem Behav 43: 925-929
65. Terry AV Jr , Buccafusco JJ, Prendergast MA, Jackson WJ, Fontana DL, Wong EHF, Whiting RL, Eglen RM (1996) The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys. NeuroReport 8:49-54
66. Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL (1994) Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14: 157-186
67. 3 receptor antagonist. RS-56812, enhances delayed matching performance in monkeys. NeuroReport 8: 49-54
68. 3H]CS 205.030. Neuroscience 31: 393-400
69. Wogar MA, Bradshaw C, Szabadi E (1992) Impaired acquisition of temporal differentiation performance following lesions of the ascending 5-hydroxytryptaminergic pathways. Psycho-pharmacology 111: 373-378
70. 3H]RS-42358-197. J Neurochem 60: 921-930
71. Yamamoto T, Hirano A (1985) Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons. Ann Neurol 17: 573-577
72. Zweig RM, Ross CA, Hedreen JC et al. (1988) The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 20: 233-242